최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기핵의학 분자영상 = Nuclear medicine and molecular imaging, v.43 no.4, 2009년, pp.309 - 316
김진숙 (전북대학교 의학전문대학원 핵의학교실) , 임석태 (전북대학교 의학전문대학원 핵의학교실) , 정영진 (전북대학교 의학전문대학원 핵의학교실) , 김동욱 (전북대학교 의학전문대학원 핵의학교실) , 정환정 (전북대학교 의학전문대학원 핵의학교실) , 손명희 (전북대학교 의학전문대학원 핵의학교실)
Purpose: F-18 FDG can be accumulated in the liver, bowel, kidney, urinary tract, and muscles physiologically. The aim of this study was to evaluate the clinical value of dual time point 18F-FDG PET /8 imaging for the differentiation of the colonic focal uptake lesions. Materials and Methods: One hun...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radioreaphics 2007;27:145-59
Israel O, Yefremov N, Bar-Shalom R, Kaqana O, Frenkel A. PET/CT detection of unexpected gastrointestinal foci of $^{18}$ F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005;46:758-62
Zhuang H, Pourdehnad M, Lambright ES, Yammoto AJ, Lanuti M, Mozley PD, et al. Dual time point $^{18}$ F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-7
Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AT. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308-12
Lodge MA, Lucas JD, Marsden PK, Cronin BF, O'Doherty MJ, Smith MA. A PET study $^{18}$ F-FDG uptake in soft tissue masses. Eur J Nucl Med 1999;26:22-30
Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point $^{18}$ F -FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871-5
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentineinduced inflammatory tissue. J Nucl Med 1995;36:1301-6
Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Doi R, et al. Delayed $^{18}$ F -fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000;89:2547-54
Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al. $^{18}F$ -FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med 2003;44:540-8
Nishiyama Y, Yamamoto Y, Monden T, Sasakawa Y, Tsutsui K, Wakabayashi H, et al. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour. Nucl Med Commun 2005;26:895-901
Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783-7
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77
Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Posit Imaging 1999;2:273-80
Liang Y-C, Tang A-W, Xu H. Diagnostic value of $^{18}$ F-FDG PET delayed imaging for patients with primary lung cancer. Chin J Nucl Med 2004;24:27-9
Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A. Potential of dual time-point imaging to improve breast cancer diagnosis with $^{18}$ F -FDG PET. J Nucl Med 2005;46:1819-24
Nishivama Y, Yamamoto Y, Fukunaqa K, Kimura N, Miki A, Sasakawa Y. Dual-time-point $^{18}$ F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med 2006;47:633-8
Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Nagai A, Ohnuki T, et al. Accuracy of PET for diagnosis of solid pulmonary lesions with $^{18}$ F-FDG uptake below the standardized uptake value of 2.5. J Nucl Med 2006;47:426-31
Hubner KF, Buonocore E, Gould HR, Thie J, Smith GT, Stephens S, et al. Differentiating benign from malignant lung lesions using “quantitative” parameters of FDG PETimages. Chin J Nucl Med 1996;21:941-9
Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H. The value of dual time point $^{18}$ F-FDG PET imaging for the differentiation between malignant and benign lesions. Clin Radiol 2008;63:756-64
Thie JA. Optimizing dual-time and serial positron emission tomography and single photon emission computed tomography scans for diagnoses and therapy monitoring. Mol Imaging Biol 2007;9:348-56
Rohren EM, Turking TG, Coleman RE. Clinical applications of PET in oncology. Radiology 2004;231:305-32
Jarritt PH, Carson KJ, Hounsell AR, Visvikis D. The role of PET/CT scanning in radiotherapy planning. Br J Radiol 2006;79:S27-35
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74
※ AI-Helper는 부적절한 답변을 할 수 있습니다.